← All stocks

RenovoRx, Inc.

RNXT Net buying
CIK 0001574094 #4619 in the set updated 20 Sep 2026
Bought (120 mo)
$264.94K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$264.94K
+$264.94K against sales at will

By person

9 insiders · 38 transactions
0.8×

Shaun R. Bagai holds only 0.8 times base salary in stock. $514.62K of shares against $583.44K in salary for 2025.

Salary from the company's own proxy. The shares are what Shaun R. Bagai last reported holding, valued at $0.79, the price Common Stock was last bought or sold at on the open market here, on 19 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Agah Ramtin
Chief Medical Officer
$171.11K (14)
+$171.11K
1,773,460
3.93%
$1.40M
−9.1%
Bagai Shaun
Chief Executive Officer
$52.76K (10)
+$52.76K
653,397
1.45%
$514.62K
+22.1%
VOLL MARK
Chief Financial Officer
$19.69K (2)
+$19.69K
416,780
0.9235%
$328.26K
+241.1%
Marton Laurence
Director
$10.22K (3)
+$10.22K
75,884
0.1681%
$59.77K
Kocak Ron
VP, Controller and PAO
$10.01K (3)
+$10.01K
12,595
0.0279%
$9.92K
Nelms Angela
Chief Operating Officer
$1.15K (2)
+$1.15K
1,100
0.0024%
$866.36
Macfarlane K. Angela
Director
(1)
$0.00
40,983
0.0908%
$32.28K
Spiegel Robert J.
Director
(1)
$0.00
40,983
0.0908%
$32.28K
RYAN UNA S
Director
97,165
0.2153%
$76.53K
Insider
Date
Role
Action
Shares
Price
Amount
VOLL MARK
19 May 2026
Chief Financial Officer
Buy
25,000
$0.79
$19.69K
VOLL MARK
20 Mar 2026
Chief Financial Officer
Buy indirect
97,200
no price
Bagai Shaun
20 Mar 2026
Chief Executive Officer
Buy indirect
24,300
no price
Marton Laurence
20 Mar 2026
Director
Buy indirect
9,720
no price
Agah Ramtin
21 Jan 2026
Chief Medical Officer
Buy
10,000
$1.00
$9.98K
Agah Ramtin
31 Dec 2025
Chief Medical Officer
Buy
9,795
$0.86
$8.42K
Agah Ramtin
30 Dec 2025
Chief Medical Officer
Buy
205
$0.83
$169.33
Bagai Shaun
18 Dec 2025
Chief Executive Officer
Buy
5,000
$0.90
$4.51K
Bagai Shaun
17 Dec 2025
Chief Executive Officer
Buy
5,000
$0.85
$4.26K
Agah Ramtin
16 Dec 2025
Chief Medical Officer
Buy
12,000
$0.85
$10.20K
Agah Ramtin
5 Dec 2025
Chief Medical Officer
Buy
10,000
$0.96
$9.60K
Agah Ramtin
24 Nov 2025
Chief Medical Officer
Buy
12,000
$0.80
$9.60K
Agah Ramtin
21 Nov 2025
Chief Medical Officer
Buy
10,000
$0.80
$8.00K
Bagai Shaun
25 Aug 2025
Chief Executive Officer
Buy
5,000
$0.91
$4.55K
Bagai Shaun
22 Aug 2025
Chief Executive Officer
Buy
5,000
$0.95
$4.75K
Agah Ramtin
5 Jun 2025
Chief Medical Officer
Buy
21,000
$1.40
$29.40K
Marton Laurence
2 May 2025
Director
Exercised, kept
20,480
$0.15
$3.07K
Bagai Shaun
15 Apr 2025
Chief Executive Officer
Buy
7,500
$0.91
$6.82K
Agah Ramtin
15 Apr 2025
Chief Medical Officer
Buy
15,000
$0.90
$13.50K
Agah Ramtin
11 Apr 2025
Chief Medical Officer
Buy
20,000
$0.80
$16.00K
Kocak Ron
10 Apr 2025
VP Controller and PAO
Buy
6,500
$0.79
$5.14K
Bagai Shaun
9 Apr 2025
Chief Executive Officer
Buy
10,000
$0.83
$8.30K
Agah Ramtin
9 Apr 2025
Chief Medical Officer
Buy
30,000
$0.81
$24.40K
Kocak Ron
9 Apr 2025
VP Controller and PAO
Buy
6,000
$0.80
$4.80K
Agah Ramtin
8 Apr 2025
Chief Medical Officer
Buy
26,000
$0.84
$21.84K
Marton Laurence
8 Apr 2025
Director
Buy
12,050
$0.85
$10.22K
Kocak Ron
8 Apr 2025
VP Controller and PAO
Buy
95
$0.80
$76.00
Bagai Shaun
7 Apr 2025
Chief Executive Officer
Buy
10,000
$0.83
$8.30K
Macfarlane K. Angela
26 Jan 2024
Director
Buy
40,983
no price
Marton Laurence
26 Jan 2024
Director
Buy
8,196
no price
Bagai Shaun
26 Jan 2024
Chief Executive Officer
Buy
40,983
no price
Spiegel Robert J.
26 Jan 2024
Director
Buy
40,983
no price
Agah Ramtin
26 Jan 2024
Chief Medical Officer
Buy
40,983
no price
Nelms Angela
3 Oct 2023
Chief Operating Officer
Buy
800
$1.05
$836.00
Nelms Angela
3 Oct 2023
Chief Operating Officer
Buy
300
$1.05
$314.97
Marton Laurence
3 Nov 2022
Director
Exercised, kept
25,438
$1.70
$43.24K
Agah Ramtin
7 Jun 2022
Chief Medical Officer
Buy
5,182
$1.93
$10.00K
Bagai Shaun
19 May 2022
Chief Executive Officer
Buy
5,500
$2.05
$11.28K

What was left out

Form 4 filings counted 89
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 8
Shares from compensation/vesting 2,666,758
History held since 4 Oct 2021